Obagi
Obagi Medical Products, commonly referred to as Obagi, is a leading name in the skincare industry, headquartered in the United States. Founded in 1988, the company has established itself as a pioneer in developing innovative skincare solutions, particularly in the realm of prescription-strength products. Obagi's primary focus areas include anti-ageing, skin health, and pigmentation correction, catering to both professional and consumer markets. With a commitment to scientific research and dermatological expertise, Obagi offers a range of unique products, including the renowned Obagi Nu-Derm System, which is designed to transform skin at the cellular level. The brand's dedication to quality and efficacy has earned it a strong market position, making it a trusted choice among skincare professionals and consumers alike. Notable achievements include numerous awards for product innovation and a loyal customer base that spans across major operational regions worldwide.
DitchCarbon Score
How does Obagi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Obagi's score of 3 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Obagi's reported carbon emissions
As of 2021, Obagi reported total carbon emissions of approximately 14,249,000 kg CO2e. This figure includes 7,342,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 6,906,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Notably, Scope 3 emissions, which encompass all other indirect emissions in the value chain, accounted for a significant 168,720,000 kg CO2e. Despite the substantial emissions figures, there are currently no publicly disclosed reduction targets or initiatives from Obagi aimed at decreasing their carbon footprint. This lack of specific commitments may reflect broader industry challenges in addressing climate change. As the company continues to operate within the global market, it remains essential for them to consider establishing measurable climate commitments to align with increasing environmental expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Scope 1 | 7,342,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 6,906,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 168,720,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Obagi is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
